We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+130.68%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$355M
AUM Growth
+$132M
(+59%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
51.07%
Top 10 Holdings %
Top 10 Hldgs %
59.98%
Holding
61
New
22
Increased
9
Reduced
5
Closed
9
Top Buys
| 1 |
Icon
ICLR
|
+$45.7M |
| 2 |
Cigna
CI
|
+$22.8M |
| 3 |
Q32 Bio
QTTB
|
+$22M |
| 4 |
Sanofi
SNY
|
+$19.7M |
| 5 |
Maximus
MMS
|
+$18.5M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
+$24.3M |
| 2 |
Labcorp
LH
|
+$13.8M |
| 3 |
Kenvue
KVUE
|
+$11M |
| 4 |
Biodesix
BDSX
|
+$7.72M |
| 5 |
Relay Therapeutics
RLAY
|
+$6.7M |
Sector Composition
| 1 | Healthcare | 91.96% |
| 2 | Industrials | 8.01% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Icon
ICLR
$13B
| $41M | 11.54% |
+195,500
| New | +$45.7M |
|
|
2
Maximus
MMS
$3.03B
| $28.5M | 8.01% |
381,423
+226,281
| +146% | +$18.5M |
|
|
3
Cigna
CI
$80.2B
| $27.1M | 7.61% |
98,003
+71,500
| +270% | +$22.8M |
|
|
4
Labcorp
LH
$22.6B
| $26M | 7.31% |
113,293
-60,000
| -35% | -$13.8M |
|
|
5
Sanofi
SNY
$103B
| $18.7M | 5.25% |
+387,000
| New | +$19.7M |
|
6
Zimmer Biomet
ZBH
$17.6B
| $18.5M | 5.2% |
174,811
+47,300
| +37% | +$5.08M |
|
|
DRUG
7
Bright Minds Biosciences
DRUG
$726M
| $16.3M | 4.58% |
+451,793
| New | +$15.9M |
|
|
AVR
8
Anteris Technologies
AVR
$871M
| $13.2M | 3.72% |
+2,370,000
| New | +$13.3M |
|
9
Annexon
ANNX
$909M
| $12.1M | 3.42% |
2,367,007
+933,852
| +65% | +$5.75M |
|
10
Teleflex
TFX
$5.76B
| $11.9M | 3.34% |
66,772
+27,500
| +70% | +$5.65M |
|
11
Viatris
VTRS
$19B
| $9.09M | 2.56% |
+730,000
| New | +$8.97M |
|
12
Organon & Co
OGN
$3.55B
| $9.05M | 2.55% |
+606,410
| New | +$9.88M |
|
|
VTYX
13
DELISTED
Ventyx Biosciences
VTYX
| $8.86M | 2.49% |
4,046,797
+2,074,849
| +105% | +$4.7M |
|
14
ANI Pharmaceuticals
ANIP
$1.83B
| $8.85M | 2.49% |
+160,051
| New | +$9.19M |
|
15
Embecta
EMBC
$184M
| $8.79M | 2.47% |
+425,574
| New | +$6.97M |
|
16
Vir Biotechnology
VIR
$1.6B
| $7.74M | 2.18% |
+1,054,651
| New | +$8.32M |
|
|
VXRT
17
DELISTED
Vaxart
VXRT
| $7.62M | 2.15% |
11,515,315
-2,092,929
| -15% | -$1.45M |
|
18
Protara Therapeutics
TARA
$230M
| $7.59M | 2.14% |
+1,437,500
| New | +$4.64M |
|
|
CRGX
19
DELISTED
CARGO Therapeutics
CRGX
| $6.82M | 1.92% |
473,292
+299,432
| +172% | +$5.43M |
|
20
Neumora Therapeutics
NMRA
$293M
| $6.74M | 1.9% |
+636,300
| New | +$7.63M |
|
|
SEPN
21
Septerna Inc
SEPN
$1.56B
| $6.22M | 1.75% |
+271,687
| New | +$6.42M |
|
22
ProQR Therapeutics
PRQR
$240M
| $5.44M | 1.53% |
+2,054,593
| New | +$6.52M |
|
23
PMV Pharmaceuticals
PMVP
$75.7M
| $5.39M | 1.52% |
3,572,167
+357,928
| +11% | +$567K |
|
24
Disc Medicine
IRON
$2.87B
| $4.66M | 1.31% |
73,511
-114,430
| -61% | -$6.62M |
|
|
ATXS
25
DELISTED
Astria Therapeutics
ATXS
| $4.51M | 1.27% |
504,887
| – | – |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA